TAZICEF 1 g/1

TAZICEF 1 g/1 is a ceftazidime injection used for treating bacterial infections. This intravenous powder solution is manufactured by Hospira, Inc. in the USA. Learn about its uses, effects, and precautions.

TAZICEF 1 g/1 is a ceftazidime injection primarily used for treating bacterial infections. It is often prescribed for conditions where bacterial resistance is a concern. Ceftazidime is a third-generation cephalosporin antibiotic, which means it works by stopping the growth of bacteria. This medication is typically administered intravenously and is used to treat a variety of infections, including those in the lungs, urinary tract, and skin.

Common effects of TAZICEF 1 g/1 may include mild to moderate reactions at the injection site, such as redness or swelling. Some individuals may experience gastrointestinal discomfort, including nausea or diarrhea. Allergic reactions, though rare, can occur and may manifest as rash, itching, or difficulty breathing. If any severe or persistent effects are noticed, it is important to consult a healthcare provider.

TAZICEF 1 g/1 should be handled with care, ensuring proper storage and preparation. It is important to follow the instructions provided by a healthcare professional for administration. Individuals with known allergies to cephalosporins or penicillin should inform their healthcare provider before use. Pregnant or breastfeeding women should discuss the potential risks and benefits with their healthcare provider.

TAZICEF 1 g/1 may interact with certain medications, including other antibiotics, diuretics, and drugs that affect kidney function. Alcohol should be avoided as it can increase the risk of side effects. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this medication.